MxA RNA quantification in febrile patients who underwent hematopoietic cell transplantation for primary immunodeficiency

Diagnostic Molecular Pathology

Volumn 20, Issue 2, 2011, Pages 111-116

  Ghidini, Claudia ^a   Zanotti, Cinzia ^a   Boccacci, Sara ^b   Lanfranchi, Arnalda ^b   Caimi, Luigi ^a   Imberti, Luisa ^a,c  

^a Biotechnology Laboratory   (Italy)

^b Spedali Civili ^*  (Italy)

^c Laboratorio di Biotecnologie   (Italy)

Author keywords

graft versus host disease; myxovirus protein A; primary immunodeficiency

Indexed keywords

MYXOVIRUS RESISTANCE PROTEIN A; RNA;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS INFECTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; ROTAVIRUS INFECTION; SCHOOL CHILD; VIRUS DETECTION; VIRUS GENOME;

CELL TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER OF UNKNOWN ORIGIN; GTP-BINDING PROTEINS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; MALE; RNA, MESSENGER; VIRUS DISEASES;

EID: 79958033190     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181fc02de     Document Type: Article

References (21)

1. Sullivan KM. Graft versus host disease. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. 3rd ed. Malden, MA: Blackwell Publishing; 2004:635-664.
2. Roy J, McGlave PB, Filipovich AH, et al. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy. Bone Marrow Transplant. 1992;10:77-82.
3. MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol BloodMarrow Transplant. 2002;8:387-394.
4. Young JA. Infectious complications of acute and chronic GVHD. Best Pract Res Clin Haematol. 2008;21:343-356.
5. Olkinuora HA, Taskinen MH, Saarinen-Pihkala UM, et al. Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic grafts. Pediatr Transplant. 2010;14:242-248.
6. Yoshimasu T, Manabe A, Ebihara Y, et al. MxA expression in patients with viral infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 2003;32:313-316. (Pubitemid 36927084)
7. Hiraoka A, Kawakami M, Fukuda H, et al. Simple diagnosis of graft-versus-host disease. J Allergy Clin Immunol. 1997;100: S70-S72.
8. Hirayama M, Azuma E, Kumamoto T, et al. Discrimination of acute graft-versus-host disease from infections by enumeration of peripheral blood interferon-gamma spot-forming cells. Transplantation. 2006;81:632-635.
9. Woo PC, Wong SS, Lum PN, et al. Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients. Lancet. 2001;357:675-679. (Pubitemid 32206426)
10. Liem LM, van Lopik T, van Nieuwenhuijze AE, et al. Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections. Blood. 1998;91:1464-1468. (Pubitemid 28086902)
11. Capra R, Sottini A, Cordioli C, et al. IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays. J Neuroimmunol. 2007;189:102-110. (Pubitemid 47385828)
12. Zanotti C, Ghidini C, Lamorgese C, et al. Transfer of myxovirusprotein- A mRNA assay for interferon-b bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A fouryear experience. Clin Chem Lab Med. 2010;48:1235-1238.
13. Halminen M, Ilonen J, Julkunen I, et al. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children. Pediatr Res. 1997;41:647-650. (Pubitemid 27183958)
14. Chieux V, Hober D, Chehadeh W, et al. MxA protein in capillary blood of children with viral infections. J Med Virol. 1999;59:547-551. (Pubitemid 29523157)
15. Von Wusson P, Jakschies D, Hochkeppel HK, et al. The human intracellular Mx-homologus protein is specifically induced by type I interferons. Eur J Immunol. 1990;20:2015-2019. (Pubitemid 20355624)
16. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev. 2009;227:75-86.
17. Przepiorka D, Weisdorf D, Marjdic P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
18. Nakabayashi M, Adachi Y, Itazawa T, et al. MxA-based recognition of viral illness in febrile children by a whole blood assay. Pediatr Res. 2006;60:770-774. (Pubitemid 44789524)
19. Watcharananan SP, Kiertiburanakul S, Piyatuctsanawong W, et al. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: Characteristics and outcome. Pediatr Transplant. 2010 [Epub ahead of print].
20. Castagnola E, Faraci M, Moroni C, et al. Rare viral infections in children receiving hemopoietic stem cell transplant. Bone Marrow Transplant. 2008;41(suppl 2):S100-S103. (Pubitemid 351864718)
21. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182-S194.